Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran
Fatimah, Anova
Unknown Affiliation
Health Professions

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Efektivitas Efepoetin Alfa dalam Mengatasi Anemia yang Disebabkan oleh Kemoterapi pada Pasien Kanker Payudara: Serangkaian Kasus: Laporan Kasus Abidin, Zainal; Fatimah, Anova
Cermin Dunia Kedokteran Vol 52 No 12 (2025): Kedokteran Umum
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v52i12.1973

Abstract

Introduction: Anemia is a common complication among cancer patients and substantially reduces quality of life (QOL) through symptoms such as fatigue and cognitive impairment. This case evaluates the use of efepoetin alfa to treat chemotherapy‑induced anemia (CIA) in late‑stage breast cancer patients in Indonesia. Case: Six Asian women aged 43–59 years with stage III breast cancer receiving docetaxel‑doxorubicin chemotherapy developed moderate anemia (mean baseline hemoglobin [Hb] 9.5 g/dL). Patients received subcutaneous efepoetin alfa (generally 0.3 mg/0.3 mL once); Hb was reassessed at an average of 8 days after the last injection. Discussion: Post‑treatment mean Hb rose to 12.1 g/dL (mean ΔHb ≈ 2.6 g/dL). No serious adverse events were observed during the short follow‑up. Conclusion: In this case, efepoetin alfa was associated with rapid increases in Hb and improved patient‑reported outcomes; however, a confirmatory larger study, standardized dosing and monitoring, and longer follow‑up are required to define efficacy and long‑term safety.
Co-Authors Zainal Abidin